High Prevalence of Hypertension in Ethiopian and Non-Ethiopian HIV-Infected Adults
Table 1
Participants’ characteristics by three levels of BP at two time points of follow-up.
Number of patients (% of total cohort)
Characteristics
Highest BP
Last visit BP
Normal
Pre-HTN
HTN
Normal
Pre-HTN
HTN
Ethnicity
Ethiopian
12 (7)
67 (39)
93 (54)
59 (34.3)
73 (42.4)
40 (23.2)
Non-Ethiopian
2 (1.9)
50 (47.2)
54 (51)
33 (31.1)
50 (47.2)
23 (21.7)
Gender
Female
9 (7.4)
61 (50.4)
51 (42.2)
51 (42.1)
50 (41.3)
20 (16.5)
Male
5 (3.2)
56 (35.7)
96 (61.2)
41 (26.1)
73 (46.4)
43 (27.3)
Age (years)
21–44
10 (5.4)
94 (51)
80 (44.1)
74 (39.5)
77 (41.1)
36 (19.2)
≥45
4 (4.2)
23 (24.4)
67 (71.2)
18 (19.7)
46 (50.5)
27 (29.6)
Overweight
No
5 (7.1)
33 (47.1)
32 (45.7)
29 (42)
26 (37.7)
14 (20.2)
Yes
0 (0)
15 (31.3)
63 (68.8)
8 (16.7)
24 (50)
16 (33.3)
Metabolic syndrome
No
5 (5.4)
46 (50)
41 (44.5)
33 (36.3)
44 (48.4)
14 (15.4)
Yes
0 (0)
1 (5.6)
17 (94.5)
0 (0)
6 (33.3)
12 (66.7)
Diabetes mellitus
0 (0)
1 (12.5)
7 (87.5)
2 (25)
2 (25)
4 (50)
Family history of CVD
No
5 (4.9)
45 (43.7)
53 (51.4)
34 (33.3)
46 (45.1)
22 (21.5)
Yes
0 (0)
4 (23.5)
13 (76.5)
2 (11.8)
6 (35.3)
9 (53)
Tobacco use
No
1 (3.1)
16 (50)
15 (46.8)
14 (43.8)
13 (40.6)
5 (15.6)
Yes
5 (5.6)
35 (38.9)
50 (55.5)
25 (28.1)
39 (43.8)
25 (28.1)
CD4 count (cells/µl)
≤200 ()
8 (6.1)
51 (38.9)
72 (54.9)
46 (34.3)
56 (42.7)
30 (23)
>200 ()
6 (4)
66 (44.8)
75 (51)
46 (29.9)
67 (47.6)
33 (22.4)
Use of HAART
No ()
4 (10.8)
16 (43.2)
17 (45.9)
15 (33.3)
22 (48.8)
8 (17.7)
Yes ()
10 (4.1)
101 (41.9)
130 (53.9)
77 (33)
101 (43.3)
55 (23.6)
Fisher’s exact test was performed for low prevalence; BP: blood pressure; HTN: hypertension; CVD: cardiovascular disease; HAART: highly active antiretroviral treatment.
